82 related articles for article (PubMed ID: 16322230)
21. NOK mediated mitogenic signaling is altered by P203L and V395I mutations.
Hou SQ; Liu L
Front Biosci (Landmark Ed); 2015 Jun; 20(7):1179-89. PubMed ID: 25961552
[TBL] [Abstract][Full Text] [Related]
22. [Preparation of anti-hNOK antibodies and expression examination of NOK in the lung cancer tissues].
Xu F; Li Y; Wang Y; Ren F; Liu L; Chang Z
Sheng Wu Gong Cheng Xue Bao; 2008 Mar; 24(3):480-4. PubMed ID: 18589826
[TBL] [Abstract][Full Text] [Related]
23. NOK/STYK1 has a strong tendency towards forming aggregates and colocalises with epidermal growth factor receptor in endosomes.
Ding X; Jiang QB; Li R; Chen S; Zhang S
Biochem Biophys Res Commun; 2012 May; 421(3):468-73. PubMed ID: 22516751
[TBL] [Abstract][Full Text] [Related]
24. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.
Mahajan NP; Whang YE; Mohler JL; Earp HS
Cancer Res; 2005 Nov; 65(22):10514-23. PubMed ID: 16288044
[TBL] [Abstract][Full Text] [Related]
25. Transmembrane helix of novel oncogene with kinase-domain (NOK) influences its oligomerization and limits the activation of RAS/MAPK signaling.
Li YH; Wang YY; Zhong S; Rong ZL; Ren YM; Li ZY; Zhang SP; Chang ZJ; Liu L
Mol Cells; 2009 Jan; 27(1):39-45. PubMed ID: 19214432
[TBL] [Abstract][Full Text] [Related]
26. NOK associates with c-Src and promotes c-Src-induced STAT3 activation and cell proliferation.
Wang Y; Liu S; Jiang G; Zhai W; Yang L; Li M; Chang Z; Zhu B
Cell Signal; 2020 Nov; 75():109762. PubMed ID: 32871210
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the transforming potential of novel anaplastic lymphoma kinase point mutants.
McDuff FK; Lim SV; Dalbay M; Turner SD
Mol Carcinog; 2013 Jan; 52(1):79-83. PubMed ID: 22086496
[TBL] [Abstract][Full Text] [Related]
28. [Expression and its Clinical Significance of NOK, EGFR in NSCLC.].
Zhang Z; Jiang T; Deng Y; Wang P; Wang J; Gu Z; Han Y; Wang Y; Zhao J; Chang Z; Li X
Zhongguo Fei Ai Za Zhi; 2009 Sep; 12(9):983-8. PubMed ID: 20719196
[TBL] [Abstract][Full Text] [Related]
29. Substrate specificity of R3 receptor-like protein-tyrosine phosphatase subfamily toward receptor protein-tyrosine kinases.
Sakuraba J; Shintani T; Tani S; Noda M
J Biol Chem; 2013 Aug; 288(32):23421-31. PubMed ID: 23814054
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic relevance of overexpressed serine threonine tyrosine kinase/novel oncogene with kinase domain (STYK1/ NOK) mRNA in colorectal cancer.
Orang AV; Safaralizadeh R; Hosseinpour Feizi MA; Somi MH
Asian Pac J Cancer Prev; 2014; 15(16):6685-9. PubMed ID: 25169509
[TBL] [Abstract][Full Text] [Related]
31. Determinants for transformation induced by the Axl receptor tyrosine kinase.
Burchert A; Attar EC; McCloskey P; Fridell YW; Liu ET
Oncogene; 1998 Jun; 16(24):3177-87. PubMed ID: 9671397
[TBL] [Abstract][Full Text] [Related]
32. NOK/STYK1 promotes the genesis and remodeling of blood and lymphatic vessels during tumor progression.
Liu Y; Li T; Hu D; Zhang S
Biochem Biophys Res Commun; 2016 Sep; 478(1):254-259. PubMed ID: 27444381
[TBL] [Abstract][Full Text] [Related]
33. Activating mutations for the met tyrosine kinase receptor in human cancer.
Jeffers M; Schmidt L; Nakaigawa N; Webb CP; Weirich G; Kishida T; Zbar B; Vande Woude GF
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11445-50. PubMed ID: 9326629
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cell proliferation and survival: convergence of protein kinases and caspases.
Duncan JS; Turowec JP; Vilk G; Li SS; Gloor GB; Litchfield DW
Biochim Biophys Acta; 2010 Mar; 1804(3):505-10. PubMed ID: 19900592
[TBL] [Abstract][Full Text] [Related]
35. A novel putative tyrosine kinase receptor with oncogenic potential.
Janssen JW; Schulz AS; Steenvoorden AC; Schmidberger M; Strehl S; Ambros PF; Bartram CR
Oncogene; 1991 Nov; 6(11):2113-20. PubMed ID: 1834974
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of receptor tyrosine kinase activation in cancer.
Du Z; Lovly CM
Mol Cancer; 2018 Feb; 17(1):58. PubMed ID: 29455648
[TBL] [Abstract][Full Text] [Related]
37. Novel oncoprotein EPS8: a new target for anticancer therapy.
Li YH; Xue TY; He YZ; Du JW
Future Oncol; 2013 Oct; 9(10):1587-94. PubMed ID: 24106906
[TBL] [Abstract][Full Text] [Related]
38. Glycoprotein non-metastatic melanoma protein B functions with growth factor signaling to induce tumorigenesis through its serine phosphorylation.
Wang C; Okita Y; Zheng L; Shinkai Y; Manevich L; Chin JM; Kimura T; Suzuki H; Kumagai Y; Kato M
Cancer Sci; 2021 Oct; 112(10):4187-4197. PubMed ID: 34327762
[TBL] [Abstract][Full Text] [Related]
39. Signalling pathways initiated by receptor protein tyrosine kinases in Drosophila.
Perrimon N
Curr Opin Cell Biol; 1994 Apr; 6(2):260-6. PubMed ID: 8024818
[TBL] [Abstract][Full Text] [Related]
40. NOK mediates glycolysis and nuclear PDC associated histone acetylation.
Shi WY; Yang X; Huang B; Shen WH; Liu L
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1792-1804. PubMed ID: 28410146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
